Navigation Links
Albemarle to Increase Price of Ibuprofen
Date:9/26/2007

BATON ROUGE, La., Sept. 26 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), a global supplier of the active pharmaceutical ingredient Ibuprofen, will increase the price of its Ibuprofen 40 micron and Ibuprofen 70 micron products by 12 percent, and its Ibuprofen 20 micron product by 20 percent, worldwide, effective October 15, 2007, or as contracts allow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

"Albemarle proudly stands behind its quality record, which is supported through decades of outstanding FDA inspection performance at our plant in Orangeburg, South Carolina," said Brian Carter, Global Business Manager, Pharmaceutical Actives. "This price increase will allow us to continue to supply the industry with a consistent, reliable supply of what we believe is the highest quality Ibuprofen available on the market today."

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for petroleum and petrochemical processing; transportation and industrial products; consumer electronics; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments, Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. For more information about Albemarle, please visit http://www.albemarle.com.

ALBEMARLE is a registered trademark of Albemarle Corporation.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.


'/>"/>
SOURCE Albemarle Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Mortality increased in Sporting enthusiasts!
3. Tattoos may significantly increase risk of hepatitis C infection
4. Increase in sugar...decrease in brain function!!!
5. Increase in tobacco deaths
6. Increased Heart Attack Risk From Celebrex,Vioxx
7. Increase in drug abuse by teenagers
8. Increase in the Number of Cases of Animal Diseases in New South Wales.
9. Metronidazole Increases Risk Of Premature Deliveries.
10. Hepatitis A Cases On A Steady Increase In Canterbury
11. Human gene number increases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may ... of groin injury, it occurs when the muscles around the pelvis become inflamed. ... around the lower torso, as well as accompanying tenderness and weakness. Without proper ...
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... ... The Anaheim Hills office accelerates and supports FNCC’s growth and further strengthens ... professionals over the past 6 months and is continuing to recruit new talent with ... of 2017. , “This new office is a direct result of our strong ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center will ... April 3rd to commemorate the two-year anniversary of the facility. The event will ... two great years while also familiarizing themselves with the facility. , In the ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  A recent study at Shriners Hospitals for Children ... the country dedicated to the treatment of pediatric burns ... the Surfacide Helios ® UV-C Disinfection System is ... pathogens not killed by the EVS (manual) cleaning process ... Burn Association,s 49th Annual Meeting in Boston ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ... to offer shares of common stock in an underwritten ... file with the Securities and Exchange Commission (the "SEC"). ... and there can be no assurance as to whether ... to the actual size or terms of the offering. ...
Breaking Medicine Technology: